2-aminobenzimidazole has been researched along with 2-amino-1-methylbenzimidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estiarte, A; Gjerstad, E; Graupe, M; Green, MJ; Hirschbein, B; Ho, JD; Janc, JW; Katz, BA; Lee, CS; Lehoux, I; Liu, L; Liu, Y; McGrath, ME; Somoza, JR; Spencer, J; Sperandio, D; Sprengeler, PA; Tai, V; Venkataramani, C; Yee, R | 1 |
| Inoue, T; Miyake, H; Morita, M; Moritomo, A; Nagashima, A; Tojo, T | 1 |
2 other study(ies) available for 2-aminobenzimidazole and 2-amino-1-methylbenzimidazole
| Article | Year |
|---|---|
Structure-guided design of peptide-based tryptase inhibitors.
Topics: Crystallography, X-Ray; Models, Molecular; Protein Conformation; Serine Endopeptidases; Serine Proteinase Inhibitors; Tryptases | 2006 |
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment.
Topics: Amine Oxidase (Copper-Containing); Amines; Animals; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Macular Edema; Male; Models, Molecular; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Thiazoles | 2013 |